The coagulopathy in acute promyelocytic leukaemia - What have we learned in the past twenty years

Best Practice and Research: Clinical Haematology

Volumn 27, Issue 1, 2014, Pages 11-18

  Kwaan, Hau C ^a   Cull, Elizabeth H ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

acute promyelocytic leukaemia; bleeding; fibrinolysis; thrombosis; tissue factor

Indexed keywords

ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; RISK FACTOR; THROMBOSIS; BLOOD; BLOOD CLOTTING TEST; BLOOD COAGULATION DISORDERS; COMPLICATION; DEFICIENCY; DISSEMINATED INTRAVASCULAR COAGULATION; FIBRINOLYSIS; FORECASTING; GRANULOCYTE PRECURSOR; HEMORRHAGIC DISORDERS; LEUKEMIA, PROMYELOCYTIC, ACUTE; METABOLISM; THROMBOPHILIA;

ANTICOAGULANT AGENT; ANTINEOPLASTIC AGENT; ANXA2 PROTEIN, HUMAN; ARSENIC TRIOXIDE; LIPOCORTIN 2; ORGANOARSENIC DERIVATIVE; OXIDE; PROTEIN S 100; RECOMBINANT PROTEIN; RETINOIC ACID; S100 CALCIUM BINDING PROTEIN A10; THBD PROTEIN, HUMAN; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR; THROMBOMODULIN; THROMBOPLASTIN; UROKINASE;

ANNEXIN A2; ANTICOAGULANTS; ANTINEOPLASTIC AGENTS; ARSENICALS; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; CARBOXYPEPTIDASE B2; DISSEMINATED INTRAVASCULAR COAGULATION; FIBRINOLYSIS; FORECASTING; GRANULOCYTE PRECURSOR CELLS; HEMORRHAGIC DISORDERS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; OXIDES; RECOMBINANT PROTEINS; RISK FACTORS; S100 PROTEINS; THROMBOMODULIN; THROMBOPHILIA; THROMBOPLASTIN; TRETINOIN; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84902162898     PISSN: 15216926     EISSN: 15321924     Source Type: Journal    
DOI: 10.1016/j.beha.2014.04.005     Document Type: Review

References (70)

1. F. Lo-Coco, and E. Ammatuna The biology of acute promyelocytic leukemia and its impact on diagnosis and treatment Hematol Am Soc Hematol Educ Program 156-161 2006 514
2. A. Melnick, and J.D. Licht Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia Blood 93 1999 3167 3215
3. Z.Y. Wang, and Z. Chen Acute promyelocytic leukemia: from highly fatal to highly curable Blood 111 2008 2505 2515
4. J. de la Serna, P. Montesinos, and E. Vellenga et al. Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin Blood 111 2008 3395 3402
5. S. Lehmann, A. Ravn, and L. Carlsson et al. Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry Leukemia 25 2011 1128 1134
6. T.J. Myers, F.R. Rickles, and C. Barb et al. Fibrinopeptide A in acute leukemia: relationship of activation of blood coagulation to disease activity Blood 57 1981 518 525
7. K.A. Bauer, and R.D. Rosenberg Thrombin generation in acute promyelocytic leukemia Blood 64 1984 791 796
8. M.S. Tallman, P. Lefebvre, and R.M. Baine et al. Effects of all-trans retinoic acid or chemotherapy on the molecular regulation of systemic blood coagulation and fibrinolysis in patients with acute promyelocytic leukemia J Thromb Haemost 2 2004 1341 1350
9. B. Bennett, N.A. Booth, and A. Croll et al. The bleeding disorder in acute promyelocytic leukaemia: fibrinolysis due to u-PA rather than defibrination Br J Haematol 71 1989 511 517
10. Y. Sakata, T. Murakami, and A. Noro et al. The specific activity of plasminogen activator inhibitor-1 in disseminated intravascular coagulation with acute promyelocytic leukemia Blood 77 1991 1949 1957
11. G. Avvisati, J.W. ten Cate, and A. Sturk et al. Acquired alpha-2-antiplasmin deficiency in acute promyelocytic leukaemia Br J Haematol 70 1988 43 48
12. A. Falanga, L. Iacoviello, and V. Evangelista et al. Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia administered all-trans-retinoic acid Blood 86 1995 1072 1081
13. A. Falanga, and F.R. Rickles Pathogenesis and management of the bleeding diathesis in acute promyelocytic leukaemia Best Pract Res Clin Haematol 16 2003 463 482
14. E. Stein, B. McMahon, and H. Kwaan et al. The coagulopathy of acute promyelocytic leukaemia revisited Best Pract Res Clin Haematol 22 2009 153 163
15. J.S. Menell, G.M. Cesarman, and A.T. Jacovina et al. Annexin II and bleeding in acute promyelocytic leukemia N Engl J Med 340 1999 994 1004
16. R. Stephens, R. Alitalo, and H. Tapiovaara et al. Production of an active urokinase by leukemia cells: a novel distinction from cell lines of solid tumors Leuk Res 12 1988 419 422
17. J.C. Meijers, E.J. Oudijk, and L.O. Mosnier et al. Reduced activity of TAFI (thrombin-activatable fibrinolysis inhibitor) in acute promyelocytic leukaemia Br J Haematol 108 2000 518 523
18. P.A. O'Connell, P.A. Madureira, and J.N. Berman et al. Regulation of S100A10 by the PML-RAR-alpha oncoprotein Blood 117 2011 4095 4105
19. R. Watanabe, M. Murata, and N. Takayama et al. Long-term follow-up of hemostatic molecular markers during remission induction therapy with all-trans retinoic acid for acute promyelocytic leukemia. Keio Hematology-Oncology Cooperative Study Group (KHOCS) Thromb Haemost 77 1997 641 645
20. H. Dombret, M.L. Scrobohaci, and P. Ghorra et al. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment Leukemia 7 1993 2 9
21. M.S. Tallman, S.A. Abutalib, and J.K. Altman The double hazard of thrombophilia and bleeding in acute promyelocytic leukemia Semin Thromb Hemost 33 2007 330 338
22. W. Zhao, X. Wang, and W. Guo et al. Hemostatic abnormalities associated with acute promyelocytic leukemia and corrective effects of all-trans-retinoic acid or arsenic trioxide treatment Chin Med J 113 2000 236 240
23. K. Webert, R.J. Cook, and C.S. Sigouin et al. The risk of bleeding in thrombocytopenic patients with acute myeloid leukemia Haematologica 91 2006 1530 1537
24. T. Barbui, G. Finazzi, and A. Falanga The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia Blood 91 1998 3093 3102
25. H.C. Kwaan, and E.M. Rego Role of microparticles in the hemostatic dysfunction in acute promyelocytic leukemia Semin Thromb Hemost 36 2010 917 924
26. G. Ma, F. Liu, and L. Lv et al. Increased promyelocytic-derived microparticles: a novel potential factor for coagulopathy in acute promyelocytic leukemia Ann Hematol 92 2013 645 652
27. T. Ikezoe, J. Yang, and C. Nishioka et al. Thrombomodulin protects endothelial cells from a calcineurin inhibitor-induced cytotoxicity by upregulation of extracellular signal-regulated kinase/myeloid leukemia cell-1 signaling Arterioscler Thromb Vasc Biol 32 2012 2259 2270
28. A. Falanga, and T. Barbui Coagulopathy of acute promyelocytic leukemia Acta Haematol 106 2001 43 51
29. H.C. Kwaan, J. Wang, and L.N. Boggio Abnormalities in hemostasis in acute promyelocytic leukemia Hematol Oncol 20 2002 33 41
30. J. Zhu, W.M. Guo, and Y.Y. Yao et al. Tissue factors on acute promyelocytic leukemia and endothelial cells are differently regulated by retinoic acid, arsenic trioxide and chemotherapeutic agents Leukemia 13 1999 1062 1070
31. R. Bach, R. Gentry, and Y. Nemerson Factor VII binding to tissue factor in reconstituted phospholipid vesicles: induction of cooperativity by phosphatidylserine Biochemistry 25 1986 4007 4020
32. J. Wang, I. Weiss, and K. Svoboda et al. Thrombogenic role of cells undergoing apoptosis Br J Haematol 115 2001 382 391
33. P. Croizat, and J. Favre-Gilly Les aspects du syndrome hémorragique des leucémies; à propos de 12 cas de thrombocytopénie et d'un cas de fibrinopénie Sang 20 1949 417 421
34. M.R. O'Donnell, M.S. Tallman, and C.N. Abboud et al. Acute myeloid leukemia, version 2.2013 J Natl Compr Canc Netw 11 2013 1047 1055
35. H.C. Kwaan, J. Wang, and I. Weiss Expression of receptors for plasminogen activators on endothelial cell surface depends on their origin J Thromb Haemost 2 2004 306 312
36. P. Fenaux Management of acute promyelocytic leukemia Eur J Haematol 50 1993 65 73
37. F. Rodeghiero, G. Avvisati, and G. Castaman et al. Early deaths and anti-hemorrhagic treatments in acute promyelocytic leukemia. A GIMEMA retrospective study in 268 consecutive patients Blood 75 1990 2112 2117
38. E. Di Bona, G. Avvisati, and G. Castaman et al. Early haemorrhagic morbidity and mortality during remission induction with or without all-trans retinoic acid in acute promyelocytic leukaemia Br J Haematol 108 2000 689 695
39. K.A. Breen, D. Grimwade, and B.J. Hunt The pathogenesis and management of the coagulopathy of acute promyelocytic leukaemia Br J Haematol 156 2012 24 36
40. A. Choudhry, and T.G. DeLoughery Bleeding and thrombosis in acute promyelocytic leukemia Am J Hematol 87 2012 596 603
41. N. Dally, R. Hoffman, and N. Haddad et al. Predictive factors of bleeding and thrombosis during induction therapy in acute promyelocytic leukemia - a single center experience in 34 patients Thromb Res 116 2005 109 114
42. M.S. Tallman, B. Brenner, and L. Serna Jde et al. Meeting report. Acute promyelocytic leukemia-associated coagulopathy, 21 January 2004, London, United Kingdom Leuk Res 29 2005 347 351
43. L. Mazzolai, K. Bouzourene, and D. Hayoz et al. Characterization of human late outgrowth endothelial progenitor-derived cells under various flow conditions J Vasc Res 48 2011 443 451
44. M.A. Sanz, D. Grimwade, and M.S. Tallman et al. Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet Blood 113 2009 1875 1891
45. E. Lengfelder, B. Hanfstein, and C. Haferlach et al. Outcome of elderly patients with acute promyelocytic leukemia: results of the German Acute Myeloid Leukemia Cooperative Group Ann Hematol 92 2013 41 52
46. C. Cordonnier, J.P. Vernant, and B. Brun et al. Acute promyelocytic leukemia in 57 previously untreated patients Cancer 55 1985 18 25
47. H.M. Kantarjian, M.J. Keating, and R.S. Walters et al. Acute promyelocytic leukemia. M.D. Anderson Hospital experience Am J Med 80 1986 789 797
48. I. Cunningham, T.S. Gee, and L.M. Reich et al. Acute promyelocytic leukemia: treatment results during a decade at Memorial Hospital Blood 73 1989 1116 1122
49. M.A. Sanz, G. Martin, and M. Gonzalez et al. Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group Blood 103 2004 1237 1243
50. S. Hashimoto, T. Koike, and W. Tatewaki et al. Fatal thromboembolism in acute promyelocytic leukemia during all-trans retinoic acid therapy combined with antifibrinolytic therapy for prophylaxis of hemorrhage Leukemia 8 1994 1113 1115
51. P. Mahendra, D.M. Keeling, and I.M. Hood et al. Fatal thromboembolism in acute promyelocytic leukaemia treated with a combination of all-trans retinoic acid and aprotonin Clin Lab Haematol 18 1996 51 52
52. J.E. Brown, A. Olujohungbe, and J. Chang et al. All-trans retinoic acid (ATRA) and tranexamic acid: a potentially fatal combination in acute promyelocytic leukaemia Br J Haematol 110 2000 1010 1012
53. A. Nosari, T.M. Caimi, and V. Zilioli et al. Cerebral hemorrhage treated with NovoSeven in acute promyelocytic leukemia Leuk Lymphoma 53 2012 160 161
54. S. Zver, D. Andoljsek, and P. Cernelc Effective treatment of life-threatening bleeding with recombinant activated factor VII in a patient with acute promyelocytic leukaemia Eur J Haematol 72 2004 455 456
55. K. Alimoghaddam, A. Ghavamzadeh, and M. Jahani Use of Novoseven for arsenic trioxide-induced bleeding in PML Am J Hematol 81 2006 720
56. N. Kawano, T. Kuriyama, and S. Yoshida et al. Clinical features and treatment outcomes of six patients with disseminated intravascular coagulation resulting from acute promyelocytic leukemia and treated with recombinant human soluble thrombomodulin at a single institution Intern Med 52 2013 55 62
57. H. Saito, I. Maruyama, and S. Shimazaki et al. Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial J Thromb Haemost 5 2007 31 41
58. N. Kawano, S. Yoshida, and N. Ono et al. Clinical features and outcomes of 35 disseminated intravascular coagulation cases treated with recombinant human soluble thrombomodulin at a single institution J Clin Exp Hematol 51 2011 101 107
59. M. Yanada, T. Matsushita, and N. Asou et al. Severe hemorrhagic complications during remission induction therapy for acute promyelocytic leukemia: incidence, risk factors, and influence on outcome Eur J Haematol 78 2007 213 219
60. E. Archimbaud, P. Fenaux, and J. Reiffers et al. Granulocyte-macrophage colony-stimulating factor in association to timed-sequential chemotherapy with mitoxantrone, etoposide, and cytarabine for refractory acute myelogenous leukemia Leukemia 7 1993 372 377
61. P. Fenaux The role of all-trans-retinoic acid in the treatment of acute promyelocytic leukemia Acta Haematol 89 Suppl. 1 1993 22 27
62. M. Breccia, G. Avvisati, and R. Latagliata et al. Occurrence of thrombotic events in acute promyelocytic leukemia correlates with consistent immunophenotypic and molecular features Leukemia 21 2007 79 83
63. J.A. Riccio, A.T. Colley, and P.J. Cera Hepatic vein thrombosis (Budd-Chiari syndrome) in the microgranular variant of acute promyelocytic leukemia Am J Clin Pathol 92 1989 366 371
64. V. De Stefano, L. Teofili, and S. Sica et al. Effect of all-trans retinoic acid on procoagulant and fibrinolytic activities of cultured blast cells from patients with acute promyelocytic leukemia Blood 86 1995 3535 3541
65. P. Montesinos, J. DlS, and E. Vellenga et al. Incidence and risk factors for thrombosis in patients with acute promyelocytic leukemia. Experience of the PETHEMA LPA 96 and LPA 99 protocols Blood 108 Suppl. 1 2011 1503
66. P. Montesinos, and M.A. Sanz The differentiation syndrome in patients with acute promyelocytic leukemia: experience of the PETHEMA group and review of the literature Mediterr J Hematol Infect Dis 3 2011 e2011059
67. S. Grisariu, G. Spectre, and Y. Kalish et al. Increased risk of central venous catheter-associated thrombosis in acute promyelocytic leukemia: a single-institution experience Eur J Haematol 90 2013 397 403
68. C.J. Roldan, S.M. Haq, and A.H. Miller Acute promyelocytic leukemia; early diagnosis is the key to survival Am J Emerg Med 31 2013 1290e1 1290e2
69. T.A. Fuchs, A. Brill, and D.D. Wagner Neutrophil extracellular trap (NET) impact on deep vein thrombosis Arterioscler Thromb Vasc Biol 32 2012 1777 1783
70. S. Dunoyer-Geindre, and E.K. Kruithof Epigenetic control of tissue-type plasminogen activator synthesis in human endothelial cells Cardiovasc Res 90 2011 457 463